NSE · VALIANTLAB
Valiant Laboratories Limited (VALIANTLAB) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,893
of 5,047 stocks
▼ 901W▼ 1551M
Peak #1,723 · 25 Oct 2026
A smallcap name in Healthcare, Valiant Laboratories Limited is growing revenue rapidly, has a subdued return on equity, and remains firmly promoter-controlled, with promoters holding 75%.
Market Cap
558.71 Cr
P/E Ratio
—
P/B Ratio
1.80
ROE
-1.05%
ROCE
0.78%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 116.77 Cr | 115.29 Cr | 91.98 Cr | 52.46 Cr |
| Net Profit | 41.34 L | 21.10 Cr | 1.76 Cr | -7.06 Cr |
| EPS | 0.08 | 3.89 | — | -1.30 |
| Operating Profit | 1.63 Cr | 27.26 Cr | 2.06 Cr | -2.31 Cr |
Shareholding pattern
Promoter
74.94%
Public
25.06%
PUBLIC BREAKDOWN
FII
0.00%
DII
0.00%
MF (within DII)
0.00%
Individuals
19.12%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 18 Jul 2025 | Rights | Rights 1:4 @ Premium Rs 65/- |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.